These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 12140911

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The neuroendocrine response to critical illness is a dynamic process.
    Vanhorebeek I, Van den Berghe G.
    Crit Care Clin; 2006 Jan; 22(1):1-15, v. PubMed ID: 16399016
    [Abstract] [Full Text] [Related]

  • 5. The dynamic neuroendocrine response to critical illness.
    Langouche L, Van den Berghe G.
    Endocrinol Metab Clin North Am; 2006 Dec; 35(4):777-91, ix. PubMed ID: 17127146
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dynamic neuroendocrine responses to critical illness.
    Van den Berghe G.
    Front Neuroendocrinol; 2002 Oct; 23(4):370-91. PubMed ID: 12381331
    [Abstract] [Full Text] [Related]

  • 9. Acute and prolonged critical illness are two distinct neuroendocrine paradigms.
    Van den Berghe GH.
    Verh K Acad Geneeskd Belg; 1998 Oct; 60(6):487-518; discussion 518-20. PubMed ID: 10230322
    [Abstract] [Full Text] [Related]

  • 10. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
    Van den Berghe G, de Zegher F, Bowers CY, Wouters P, Muller P, Soetens F, Vlasselaers D, Schetz M, Verwaest C, Lauwers P, Bouillon R.
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Endocrine modifications and interventions during critical illness.
    Weekers F, Van den Berghe G.
    Proc Nutr Soc; 2004 Aug; 63(3):443-50. PubMed ID: 15373956
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Systemic illness.
    Bondanelli M, Zatelli MC, Ambrosio MR, degli Uberti EC.
    Pituitary; 2008 Aug; 11(2):187-207. PubMed ID: 18404385
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues.
    Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, Gouwy S, Stockman W, Weekers F, Schetz M, Lauwers P, Bouillon R, Bowers CY.
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):599-612. PubMed ID: 9425400
    [Abstract] [Full Text] [Related]

  • 19. Hormonal and metabolic strategies to attenuate catabolism in critically ill patients.
    Vanhorebeek I, Van den Berghe G.
    Curr Opin Pharmacol; 2004 Dec; 4(6):621-8. PubMed ID: 15525554
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.